Rarity Bioscience closed a EUR 6.5M funding round led by Navigare Ventures.
Rarity Bioscience is focused on advancing precision medicine through ultra-sensitive mutation detection technology, specifically their superRCA® platform, which enables the detection of low-frequency mutations in various clinical settings
Rarity Bioscience is focused on advancing precision medicine through ultra-sensitive mutation detection technology, specifically their superRCA® platform, which enables the detection of low-frequency mutations in various clinical settings.